Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 800-926-8273
Fax+1 888-539-8781
Dr. Salmasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Clinical and Translational Science Institute, UCLAMSCR, 2016 - 2018- Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Urology, 2011 - 2015
Rutgers Health/Robert Wood Johnson Medical SchoolResidency, Surgery, 2009 - 2011
Tehran University of Medical Sciences School of MedicineClass of 2004
Certifications & Licensure
CA State Medical License 2015 - 2026
NJ State Medical License 2013 - 2017
American Board of Urology Urology
Publications & Presentations
PubMed
- Natural History of subcentimeter pulmonary nodules in clinical stage I seminoma patients.Nuphat Yodkhunnatham, Dhruv Puri, Kshitij Pandit, Austin Leonard, Isabella Dolendo
Urologic Oncology. 2025-04-01 - Metabolic Syndrome Among Testicular Cancer Survivors: Long-Term Follow-Up of the Veterans Affairs Health System.Dhruv Puri, Paul Riviere, Margaret Meagher, Kylie Morgan, Tyler Nelson
Cancer Medicine. 2025-04-01 - Osteoporosis Amongst Testicular Cancer Survivors: Long Term Follow-Up of the Veterans Affairs Health System.Nuphat Yodkhunnatham, Paul Riviere, Kshitij Pandit, Kylie Morgan, Margaret Meagher
Clinical Genitourinary Cancer. 2025-03-19
Journal Articles
- Detection of Individual Prostate Cancer Foci via Multiparametric Magnetic Resonance ImagingSteven S Raman, Sohrab A Mirak, Izak Faiena, Aydin Pooli, Amirali Salmasi, Ely R Felker, European Urology
- Radical Prostatectomy Then and Now: Surgical Overtreatment of Prostate Cancer Is Declining from 2009 to 2016 at a Tertiary Referral CenterAmirali Salmasi, Izak Faiena, Karim Chamie, Urologic Oncology
Authored Content
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
- Re: Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After NephrectomyFebruary 2018
Press Mentions
Unio Specialty Care: Advancing the Healthcare Paradigm Shift in Urology and Gastroenterology Towards Value-Based CareJuly 29th, 2024- Medical Moment: Using Blue Light to Identify Bladder CancerJanuary 7th, 2024
- Gene Therapy for Bladder Cancer Enters ClinicsJuly 10th, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Society of Urologic Oncology - SUOMember
- San Diego Center for Precision ImmunotherapyMember
Other Languages
- Farsi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
